Nefense, a company focused on advanced clinical hygiene and airway health solutions, announced the launch of its Hypochlorous Acid (HOCl) nasal spray line, introducing an age-specific approach to respiratory defense. The product expansion includes formulations for adults, children, and infants, addressing the need for safe and effective nasal care across different age groups.
The flagship product, Hyponasal spray, delivers a clinical-grade biocleanse that flushes irritants, provides soothing relief, and supports natural respiratory defenses without harsh chemicals or steroids. Powered by hypochlorous acid, the formulation offers broad-spectrum antimicrobial and anti-inflammatory action, neutralizing bacteria and viruses, helping prevent upper respiratory infections, and combating seasonal allergies. This launch positions Nefense to meet growing consumer demand for non-pharmaceutical options in respiratory health.
According to the company, the hypochlorous acid technology is known for its safety and efficacy, mimicking the body's natural immune response. The age-specific formulations are designed to ensure appropriate dosing and delivery for vulnerable populations, including infants and children. This tailored approach could help reduce the risk of overuse or adverse effects often associated with generic products.
The announcement highlights a broader trend in the hygiene and wellness industry toward preventative care and natural solutions. As respiratory infections and allergies continue to impact public health, products like Nefense's nasal spray line offer a proactive tool for maintaining airway health. The company states that many clinics and practices nationwide already offer in-store purchases of the Nefense nasal spray family, including XyloClean, a xylitol-based nasal spray designed to moisturize and rebalance nasal passages.
Nefense's collaboration with doctors and ENT specialists underscores its commitment to science-driven innovation. By bridging daily hygiene with airway health, the company aims to help people breathe better and live healthier. The launch of the HOCl nasal spray line represents a significant step in expanding respiratory care options for consumers seeking effective, gentle alternatives.
